CClinicalTrials.gg
CompletedNCT04331431Updated Apr 2, 2020

Outcomes of the Intradural Extramedullary Tumors Resection

An interventional study of Spinal cord tumor resection in Spinal Cord Tumor, sponsored by Sohag University. Completed. Open to participants aged 28 Years to 66 Years. Per ClinicalTrials.gov, last updated 2020-04-02.

Sponsored by Sohag University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 11 years 11 months after the study started (first participant enrolled Apr 2008, registered Mar 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Not applicable
Ages
28 Years to 66 Years
Sex
All
01

Study summary

The intradural extramedullary tumors remain curable diseases. Our aim in this study is to evaluate the postoperative status after the tumor resection and compare it to the preoperative status

Read the detailed description

Meticulous microscopic excision without nerve root or dural injuries

02

Conditions studied

  • Spinal Cord Tumor

Browse trials for

03

In context

Spinal Cord Neoplasms

88 studies on the registry are indexed under Spinal Cord Neoplasms; 26 are open to participants now.

This study's enrollment of 24 is below the median of 55 across 53 interventional studies indexed under Spinal Cord Neoplasms.

Browse Spinal Cord Neoplasms studies →

Lead sponsor

Sohag University is the lead sponsor of 1,183 studies on the registry; 612 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
28 Years to 66 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • neurological deficit
  • back pain

Exclusion criteria

Exclusion Criteria:

  • old age above 80 years
  • immunocompromised patients
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
24 participants (actual)

Study arms

  • Other
    spinal cord tumors

    Procedure: Spinal cord tumor resection

Interventions

  • ProcedureSpinal cord tumor resection

    Excision of intradural tumors

06

What researchers measure

Primary outcomes

  1. complete excision

    delicate dissection

    Time frame: 7 years

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 2, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04331431
Lead sponsor
Sohag University
Responsible party
ahmed salaheldin mohammed saro (Assistant professor of neurosurgery, Sohag University) — Principal investigator
First posted
Apr 2, 2020
Start date
Apr 1, 2008
Primary completion
Apr 1, 2015
Completion
Apr 8, 2015
Last update
Apr 2, 2020

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion